share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer O'Hara Elaine

諾瓦瓦克斯醫藥 | 4:持股變動聲明-高管 O'Hara Elaine

SEC announcement ·  03/06 08:34
牛牛AI助理已提取核心訊息
On March 1, 2024, Elaine O'Hara, EVP and Chief Strategy Officer of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. O'Hara acquired 19,600 shares at a price of $5.39 per share through the exercise of derivative securities. On the same day, she disposed of 5,375 shares at the same price, which was related to the payment of exercise price or tax liability by delivering or withholding securities. After these transactions, O'Hara's direct holdings in Novavax common stock amounted to 14,225 shares. The total market value of the disposed shares was calculated to be $28,971.25.
On March 1, 2024, Elaine O'Hara, EVP and Chief Strategy Officer of Novavax Inc (NVAX), completed a stock transaction involving the company's common stock. O'Hara acquired 19,600 shares at a price of $5.39 per share through the exercise of derivative securities. On the same day, she disposed of 5,375 shares at the same price, which was related to the payment of exercise price or tax liability by delivering or withholding securities. After these transactions, O'Hara's direct holdings in Novavax common stock amounted to 14,225 shares. The total market value of the disposed shares was calculated to be $28,971.25.
2024年3月1日,Novavax Inc(NVAX)執行副總裁兼首席戰略官伊萊恩·奧哈拉完成了一項涉及該公司普通股的股票交易。奧哈拉通過行使衍生證券,以每股5.39美元的價格收購了19,600股股票。同日,她以相同價格出售了5,375股股票,這與通過交付或預扣證券支付行使價或納稅義務有關。在這些交易之後,奧哈拉直接持有的Novavax普通股爲14,225股。經計算,已處置股票的總市值爲28,971.25美元。
2024年3月1日,Novavax Inc(NVAX)執行副總裁兼首席戰略官伊萊恩·奧哈拉完成了一項涉及該公司普通股的股票交易。奧哈拉通過行使衍生證券,以每股5.39美元的價格收購了19,600股股票。同日,她以相同價格出售了5,375股股票,這與通過交付或預扣證券支付行使價或納稅義務有關。在這些交易之後,奧哈拉直接持有的Novavax普通股爲14,225股。經計算,已處置股票的總市值爲28,971.25美元。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。